Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

This publication has 11 references indexed in Scilit:

• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
  Published by Elsevier ,2004
• Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
  Nature, 1984
• Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
  Nature, 1984
• Differential inhibition of mitochondrial respiratory control by N-1-substituted, 3-, 4-substituted pyridinium halides
  Cellular and Molecular Life Sciences, 1984
• Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice
  Science, 1984
• Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey
  Brain Research, 1984
• Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse
  European Journal of Pharmacology, 1984
• Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
  Science, 1983
• Chronic parkinsonism secondary to intravenous injection of meperidine analogues
  Psychiatry Research, 1979
• AN APPRAISAL OF THE USE OF MONOAMINE OXIDASE AS AN ENZYME MARKER FOR THE OUTER MEMBRANE OF RAT LIVER MITOCHONDRIA
  The Journal of cell biology, 1970